JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 23, 2005; DOI: 10.1124/jpet.105.088153


0022-3565/05/3151-188-195$20.00
JPET 315:188-195, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.088153v1
315/1/188    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canonaco, M.
Right arrow Articles by Facciolo, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canonaco, M.
Right arrow Articles by Facciolo, R. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*3-NITROPROPIONIC ACID
Medline Plus Health Information
*Degenerative Nerve Diseases

NEUROPHARMACOLOGY

The Histaminergic Signaling System Exerts a Neuroprotective Role against Neurodegenerative-Induced Processes in the Hamster

Marcello Canonaco, Maria Madeo, Raffaella Alò, Giuseppina Giusi, Teresa Granata, Antonio Carelli, Alessia Canonaco, and Rosa Maria Facciolo

Comparative Neuroanatomy Laboratory, Ecology Department, University of Calabria, Ponte Pietro Bucci, Cosenza, Italy (M.C., M.M., R.A., G.G., T.G., An.C., R.M.F.); and Faculty of Medicin, La Sapienza University of Rome, Rome, Italy (Al.C.)

Received April 22, 2005; accepted June 15, 2005.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
The neurotoxic 3-nitropropionic acid (3-NP), a freckled milk vetch-derived inhibitor of mitochondrial enzymatic processes that is capable of mimicking the typical pathological features of neurodegenerative disorders, behaved in a differentiated manner in a hibernating rodent (hamster) with respect to a nonhibernating rodent (rat). Treatment of the two rodents with both an acute and chronic 3-NP dose supplied deleterious neuronal effects due to distinct histamine receptor (HnR) transcriptional activities, especially in the case of the rat. In hamsters, these treatment modalities accounted for overall reduced global activity in a freely moving environment and overt motor symptoms such as hindlimb dystonia and clasping with respect to the greater abnormal motor behaviors in rats. This behavioral difference appeared to be strongly related to qualitative fewer neuronal alterations and, namely, lesser crenated cell membranes, swollen mitochondria, and darkened nuclei in hamster brain areas. Moreover, a mixed H1,3R mRNA expression pattern was reported for both rodents treated with a chronic 3-NP dose as demonstrated by predominantly low H1R mRNA levels (>50%) in rat striatum and cortex, whereas extremely high H3R levels (>80%) characterized the lateral and central amygdala nuclei plus the striatum of hamsters. Interestingly, the H3R antagonist (thioperamide) blocked 3-NP-dependent behaviors plus induced an up-regulation of H1R levels in mainly the above-reported hamster amygdalar nuclei. Overall, these results show, for the first time, that a major protective role against neurodegenerative events appears to be strongly related to the expression activity of H1,3R subtypes of amygdalar neurons in this hibernating model.


Ever since the establishment of the sedative actions of classical antihistamines, it has become clear that this neuronal mediating system, recognized initially for its allergic reactions, is involved in many vital brain functions such as pain, feeding, sleeping, and thermoregulation (Orthen-Gambill and Salomon, 1992Go; Sakata et al., 1997Go; Parmentier et al., 2002Go). The histaminergic neuronal fibers, originating from the hypothalamus, are projected extensively in the brain and promote their actions via three pharmacologically distinct receptor subtypes denoted as HnR (H1–3R) (Leurs et al., 2005Go). The results of this and other studies have established that all subtypes display a postsynaptic location, with the exception of H3R, which has instead shown to be located at both presynaptical and postsynaptical sites. A distribution pattern that appears to be tightly correlated to some of the above homeostatic mechanisms, namely eating behaviors and thermoregulation, which are typically controlled by the different subtypes of the hypothalamic nuclei (Haas and Panula, 2003Go). Moreover, broad effects of H3R blockade with selective and more potent inverse agonists have recently linked the activities of this subtype to the impairment of aging parameters, disturbances of cognition functions along with sensorimotor deficits that are considered to be the more common deleterious features of central nervous system disorders such as Alzheimer's disease (AD) and schizophrenia (Fox et al., 2005Go).

Accumulating data dealing with neurodegenerative disorders have suggested the neurotoxicant 3-nitropropionic acid (3-NP), a plant (freckled milk vetch)-derived blocker of mitochondrial respiration, to be a valuable chemical agent for the establishment of biomolecular events in such disorders (Bizat et al., 2003Go). 3-NP, which manages to enter in humans by accidental ingestion of contaminated mildewed sugar cane (Deshpande et al., 1997Go), is capable of inducing necrotic and apoptotic events in some cerebral regions. Thus, it mimicks salient motor and neuropathological features that typically resemble those reported for patients suffering from neuropathologies such as Huntington's disease (Fernagut et al., 2002Go), AD, and cerebral ischemia (Pang and Geddes, 1997Go).

Recently, 3-NP has been used in ischemic preconditioning paradigms (Brambrink et al., 2004Go) from which have been defined adaptable neuroprotective mechanisms that are induced in oxygen-deprived activities of AD (Higuchi et al., 2000Go) as well as in animals during hibernation (Stenzel-Poore et al., 2003Go). On the basis of these results, it seemed interesting to propose the effects of the freckled milk vetch-derived neurotoxin in a highly appropriate hibernating model, the Syrian golden hamster. This rodent is a permissive hibernator that undergoes profound neurophysiological modifications, following particular environmental conditions such as hypothermia, which allow the animal to survive through these extraordinary conditions (Ueda and Ibuka, 1995Go). As a matter of fact, it is throughout the different hibernating stages in rodents, i.e., during enter, torpor, and arousal states, that brain vascular homeostasis plus the reprogramming of gene expression (Epperson and Martin, 2002Go) are strongly influenced by neuronal mediators such as the histaminergic system (Panula et al., 2000Go). In this context, it was the intention of the present study to investigate 3-NP-dependent neurodegenerative effects on the transcriptional activity of the two main histaminergic subtypes (H1,3R) plus neuronal ultrastructural changes in key brain areas of the sensory and incentive motivational circuit (Balleine et al., 2003Go) such as the cortical layers and amygdala. These effects were compared with the major motor controlling brain center (striatum) to identify not only the specific subtype but also the brain site(s) that may be linked with neuroprotective processes adopted by this hibernating rodent model.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
Animal Treatment. The effects of an i.p. 10-day chronic (20–900 mg/kg) and 1-day acute (50–200 mg/kg) 3-NP treatment (dissolved in saline solution) on motor activities were evaluated 2 h after drug administration (within the survivability period of the animal) on the adult (90-day-old) hibernating rodent model, the Syrian golden hamsters (Charles River Italica, Calco, Italy), with respect to hamsters (control) that only received vehicle. In the same manner, the effects of this neurotoxin were assessed in a nonhibernating rodent, the Wistar rat (Charles River Italica) of the same age group. A semi-quantitative scale for motor disorder as in previous studies (Fernagut et al., 2002Go) was used to assess severity rating by a three-level scale of the following five items in the symptomatic rat (up to 100 mg/kg) and hamster (up to 200 mg/kg) and asymptomatic animals. A value ranging from 0 to 2 was assigned to each type of behavior for a maximal score of 10 for all behaviors that constitute the main motor symptoms: hind limb clasping, reduced global activity in a freely moving environment, hind limb dystonia, truncal dystonia, and balance adjustments to a postural challenge. Due to the extreme vulnerability effects of chronic 3-NP doses in rats, the role of histamine blockers was carried out on only acute-treated animals. For this part, both rats and hamsters received, 1 h before 3-NP treatment, a single dose (i.p.) of the H3R antagonist thioperamide (10 mg/kg body weight), whereas other animals received a combined dose containing H1R antagonist pyrilamine (20 mg/kg body weight) and H2R antagonist cimetidine (200 mg/kg body weight), a combination that is capable of successfully regulating neuronal transcriptional activities (Patkai et al., 2001Go).

For ultrastructural and H1,3R transcription studies, the brain of both rodents was rapidly removed 12 h after treatment for all groups and stored, in the case of the latter study, at –40°C for further analyses. Animal maintenance and all experimental procedures were carried out in accordance with the Guide for Care and Use of Laboratory Animals issued by the European Communities Council Directive (1986Go) (86/609/EEC). Efforts were made to minimize animal suffering and reduce the number of specimens used.

Ultrastructure. The ultrastructure of neurons in some encephalic regions of all animal models was carried out in perfusion-fixed (4% glutaraldehyde) brains. Amygdalar, striatal, and cortical regions of both rodents were carefully dissected out using the coordinates that are reported in the rat (Paxinos and Watson, 1982Go) and hamster (Morin and Wood, 2001Go) brain atlases; after, dehydrated blocks of tissue were embedded in Epon 812, and the ultrathin sections were examined using the Zeiss EM 900 transmission electron microscope (Carl Zeiss GmbH, Jena, Germany).

To estimate the neuromorphological effects of 3-NP, quantitative analysis was carried out on some major motor and motivational controlling brain areas such as striatum and amygdala of hamsters treated with an acute dose of this neurotoxin and compared with that of rats. For this part, semithin sections that were obtained from the above isolated telencephalic regions were counterstained with toluidine blue, and total numbers of damaged and normal neurons were assessed with a 40x objective with a Vidas Image Analyzer (Carl Zeiss GmbH) using a 6.5 x 6.5 grid composed of 42 test points and 21 test lines. Neurons with round nuclei, visible nucleoli, and clear cytoplasma lying within the grid were considered undamaged, whereas neurons with shrunken nuclei and vacuolated dark cytoplasma (dark cells) were considered damaged. Because many degenerating profiles were included in such counts and given that the pathological processes may alter the normal ultrastructural features of neurons and nonneuronal cells, the identification of degenerating elements belonging to one or another cell type is necessarily tentative and based purely on comparisons with normal cells (Kuljis et al., 1997Go).

Amino Cupric Silver Stain. The identification of neuron degeneration due to 3-NP treatment was handled according to the precipitation of ionic silver staining methods (De Olmos et al., 1994Go). Briefly, for this part, brain sections (30 µm) of animals exposed to the freckled milk vetch neurotoxin were initially preimpregnated with a series of nitrates (such as silver and others), subsequently impregnated with silver nitrate, lithium, and ammonium hydroxides, and stained with neutral red (Thermo Electron Corporation, Milan, Italy). The chemical-dependent subcellular damages were observed and evaluated with a bright-field Dialux EB 20 microscope (Leitz, Wetzlar, Germany).

H1,3R Transcription Activity. The sequence of H1,3R, determined from total RNA of 3-NP-treated whole brains of both rodents, was prepared with TRI reagent (Sigma-Aldrich, St. Louis, MO) and finally dissolved in diethyl pyrocarbonate-water (Sigma-Aldrich). Reverse transcription reaction was performed using 2 µg of total RNA with RETROscript kit (Celbio, Milan, Italy) at 44°C for 1 h after template denaturation at 75°C for 3 min. Amplification of H1R and H3R was performed using EuroTaq Polymerase (Celbio) with gene-specific primer sets.

Synthetic oligonucleotide probes (Roche Applied Science, Indianapolis, IN) were designed from sequencing of the above PCR products. The antisense probes were complementary to encoding sequence bp 850 to 894 and bp 829 to 870 of the mature protein, respectively, for H1R and H3R. To perform in situ hybridization on 3-NP-treated rat and hamster brains, antisense and sense probes were labeled by 3'-tailing with digoxigenin-11-dUTP according to the DIG oligonucleotide tailing kit provided by Roche Applied Science. The reaction was incubated at 37°C for 30 min and then stopped with 0.2 M EDTA, pH 8.0. Probe concentration was determined by quantification against known standards on Hybond N+ filters (Amersham Biosciences Inc., Piscataway, NJ). Briefly, brains sections (10 µm) mounted on polylysine-coated slides (Thermo Electron Corporation) were stored at –40°C; subsequently, 100 ng of antisense probe in 100 µl of hybridization solution was added for each section before overnight in situ hybridization at 50°C in a humidified chamber according to Kia et al. (2002Go). Nonspecific hybridization was obtained on slides incubated with the sense probe. For immunological detection, sections were coverslipped for 45 min with phosphate-buffered saline containing 2% normal sheep serum (Sigma-Aldrich) and 0.3% Triton X-100 (Sigma-Aldrich); subsequently, 1:100 anti-digoxigenin alkaline phosphatase antibody (Roche Applied Science) was added for 2 h at room temperature, and the alkaline phosphatase color reaction buffer (nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate) was added to sections and incubated for 72 h in a humidified dark chamber. The neuronal hybridization signals were observed at a bright-field Dialux EB 20 microscope (Leitz) under a phase-contrast objective (x40), and transcriptional activity was evaluated with a Panasonic Telecamera (Canon Objective Lens FD, 50 mm, 1:3.5) attached to a Macintosh computer-assisted image analyzer system running an Image software of the National Institutes of Health. The data, expressed as the mean ± S.E.M., were evaluated by one-way analysis of variance followed, where necessary, by Student's t test.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
Effects of 3-NP at the Cellular Level. The influences of acute and/or chronic 3-NP treatment on the promotion of neurodegenerative processes were initially correlated to the onset of abnormal motor behaviors that were induced by the two treatment modalities (Bizat et al., 2003Go). A first major behavioral result consisted of less vulnerable effects produced by this freckled milk vetch neurotoxin in the hibernating rodent, even for those doses (100 mg/kg; 50 mg/ml) that in the rat are considered to be very lethal as shown by the immediate overt motor symptoms such as hind limb and truncal dystonia, hind limb clasping, and reduced global activity (Fig. 1).



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1. Species-dependent behavioral effects of the freckled milk vetch-derived neurotoxin (3-NP) in animals (n = 5) treated with an acute dose of this neurotoxin. Scores (mean ± S.E.M.) of main behaviors (hind limb clasping, reduced global activity, hind limb dystonia, truncal dystonia, and postural adjustments) were analyzed for different doses in the rat (gray) and hamster (black) and compared with their respective controls. On the basis of approaches used in other studies (Fernagut et al., 2002Go), a maximum value of 2 was attributed to each behavior manifested such that a maximum of 10 could be assigned to the animals. *, p < 0.05; ***, p < 0.001.

 
The application of amino cupric silver staining methods in the brain of both rodents consented a rapid detection of neuronal damages in regions that are involved with the execution of the above and other stereotyped behaviors. Indeed, an evident argyrophilic reaction that characterizes neuronal damages was demonstrated in the striatal areas of the rat (Fig. 2a) as displayed by the notably dark neuronal perikarya in dendrites and axons with respect to the fewer number of dark cells in some amygdalar and cortical areas of the hamster (III–V; Fig. 2b). Subsequent ultrastructural observations further confirmed that, despite neuronal damages observed in the two rodents following either a chronic and/or an acute 3-NP treatment schedule, these damages were still of a lesser entity in the hamster. As a matter of fact, preliminary data displayed that the 48% damaged dark neurons characterized the striatum of 3-NP-treated rats with respect to the 18% dark cells detected in controls. This value may be regarded as consistently high if we consider that comparable numbers of dark neurons (37%) were estimated in the same brain area of 3-NP-treated hamster, whereas a value of 30% dark neurons was instead obtained for amygdalar areas of treated hamsters with respect to 20% reported for controls. In particular, qualitative observations displayed a shrunken, crenated cell membrane plus a more electron-dense (darkened) cytoplasm containing confluent vacuolated spaces (Fig. 2c) that were mostly distributed in the various rat striatal and amygdalar areas as well as cortical layers, independent of the type of 3-NP treatment modality. Smaller and darker nuclei displaying a relatively homogeneous chromatin along with a very enlarged nucleoli (Fig. 2d) and an apparent increase of swollen mitochondria (Fig. 2e) were mostly typical of rats treated with 3-NP. In addition, the synaptic elements were neither numerically abundant nor did they present structurally distinct pre- and postsynaptic membranes (Fig. 2f). Regarding the structural modifications in the hamster, a moderately high number of lobulated shrunken and dark nuclei displaying a relatively homogeneous chromatin plus very enlarged nucleoli seemed to also characterize a fair number of neurons in amygdalar and cortical areas (Fig. 2g). This condition was in any case appreciably lower than that of rats as emphasized by the above percentage differences of dark versus normal neurons. Moreover, even for the vascular structures, a notable number of ischemic-like alterations such as edematous perivascular areas were detected in this hibernating rodent independent of the 3-NP treatment modality (Fig. 2h).



View larger version (107K):
[in this window]
[in a new window]
 
Fig. 2. Photomicrographs showing different cellular damages in some brain regions (n = 3) of the hamster and rat treated with 3-NP. Amino cupric silver stain methods allowed the observation (magnification x16) of early damages in rat striatum (a) and hamster cortex (b) after acute doses (100 and 200 mg/kg body weight, respectively) of the neurotoxin. Ultrastructural photomicrographs of neuronal components of 3-NP-treated animals showing nuclear and cytoplasmic degeneration in striatum (c; magnification x10,000) of acute-treated rat. The amygdala (magnification x3000) of this same group (d and e) featured numerous dark neurons with enlarged nucleolus (white asterisk) plus swollen mitochondria (magnification x15,000; black arrow), whereas the cortex of chronic treated rat (200 mg/kg body weight) exhibited a high number of degenerated synapses (f; magnification x40,000). Fewer neuronal damages were instead observed in hamster amygdala (g; magnification x6000) as well as few edematous vessels (arrowhead) in the striatum (h; magnification x3000) of this same rodent that received a chronic 3-NP dose (900 mg/kg body weight).

 

Effects of 3-NP on H1,3R Transcription Activity. With the aim of evaluating whether these degenerative processes included damages of the histaminergic signaling system, the expression levels and sequence pattern of the major HnR subtypes (H1/3R) were determined in some brain regions of the hamster and rat. From the reverse transcriptase-PCR investigations, it was possible to observe a high degree of nucleotide homology (>85%) for the two subtypes in both rodents (Fig. 3a). This homology was further confirmed by the very similar amino acid sequence of H3R with the exception of some substitutions and, in particular, isoleucine and leucine being replaced by lysine and asparagine at positions 225 and 233, respectively, of the third intracellular loop in the hamster.



View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3. Influences of 3-NP on brain expression of HnR subtypes in rat (n = 5) and hamster (n = 5). a, electrophoresis gel of PCR products for H1R and H3R of brains of both rodents treated with 3-NP. Transcription expression values (relative mean O.D. ± S.E.M.) of H1R (b and d) and H3R (c and e) mRNAs were evaluated after acute (b and c) and chronic (d and e) 3-NP doses in the symptomatic (gray) rat and asymptomatic (striped) hamster and compared with their corresponding control (white) as described under Materials and Methods. *, p < 0.05; **, p < 0.01; ***, p < 0.001. Bl, basolateral amygdala nucleus; CORIII, cortex layer III; COR V, cortex layer V; Co-Me, corticomedial amygdala nucleus; Str, striatum.

 
If the abnormal motor behaviors of this freckled milk vetch-derived neurotoxin did not seem to be related to any nucleotide sequence differences, it was, rather, the notable expression pattern of H1R and H3R neurons in some brain areas that appeared to be correlated to the abnormal motor behaviors. Indeed, treatment of both the hamster and rat with either an acute or chronic 3-NP dose provided a substantially mixed expression pattern of both subtypes. In a first case, a marked down-regulation (>60 < 80%; p < 0.01) of mostly H1R-expressing neurons characterized both the cortex layers (III and V) and striatum of the symptomatic rat (Fig. 3b), especially after an acute dose of 50 mg/kg 3-NP. The hamsters, on the other hand, did not display any net differences for the two subtypes, aside from the greater (>60 < 80%; p < 0.01) H3R-expressing neurons in COR V (Fig. 3c) even after a greater acute dose (100 mg/kg) than that given to the rat. A trend that was still maintained when both rodents received a chronic 3-NP treatment as demonstrated by predominantly greater changes of the two subtypes occurring only in the cortical layers, striatum, plus some amygdalar nuclei of the rat (Fig. 3, d and e).

The absence of any type of transcriptional variations in the hamster could very well be attributed to the asymptomatic state that characterized this hibernating rodent model with respect to the symptomatic state of the rat. As a matter of fact, when the hamster received an acute dose, which was responsible for no abnormal motor behaviors with respect to a dose (200 mg/kg) capable of promoting symptomatic conditions, a marked down-regulation of H1R neurons was obtained in a comparable manner with COR V of the symptomatic rat (Fig. 4a). A somewhat similar condition was detected not only in this cortical layer but also in the lateral amygdala nucleus (Lat) and central amygdala nucleus (Ce) (>40%, p < 0.05) (Fig. 4c) of the hamster. Conversely, a very evident (>80%, p < 0.001) up-regulation of H3R neurons in COR III (Fig. 4b), and the majority of the amygdalar areas (Fig. 4d) appeared to be also linked to the symptomatic conditions of the hamster. This substantial up-regulating trend for H3R neurons in COR V (Fig. 5a) and above all in Ce, Lat, and basolateral amygdala nucleus (Fig. 5c) was conserved (>130%, p < 0.001) even after a chronic treatment that accounted for exaggerated motor abnormalities such as truncal and hind limb dystonia, despite a nonsignificant up-regulating activity of H1R neurons resulting in only the corticomedial amygdala nucleus (Fig. 5d) with respect to the marked low levels in most rat brain areas such as COR III (Fig. 5b).



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4. The expression differences of H1R (a and c) and H3R (b and d) mRNAs in acute-induced symptomatic and asymptomatic animals. Transcription expression values (relative mean O.D. ± S.E.M.) of the two subtypes refer to some cortical (a and b) and amygdalar (c and d) areas of the symptomatic (gray) rat (n = 5) treated with an acute dose of 3-NP (100 mg/kg body weight) and of the symptomatic (black) and asymptomatic (striped) hamsters (n = 5) also treated with an acute dose of 3-NP (200 and 50 mg/kg body weight, respectively) and compared with their corresponding controls (white) as reported under Materials and Methods. *, p < 0.05; **, p < 0.01; ***, p < 0.001. For abbreviations, check Fig. 3.

 


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5. The expression differences of H3R (a and c) and H1R (b and d) mRNAs in chronic-induced symptomatic and asymptomatic animals. Transcription expression values (relative mean O.D. ± S.E.M.) of the two subtypes refer to some cortical (a and b) and amygdalar (c and d) areas of the symptomatic (gray) rat (n = 5) treated with a chronic dose of 3-NP (200 mg/kg body weight) and of the symptomatic (black) and asymptomatic (striped) hamsters (n = 5) also treated with a chronic dose of 3-NP (900 and 500 mg/kg body weight, respectively) and compared with their corresponding controls (white) as reported under Materials and Methods. *, p < 0.05; **, p < 0.01; ***, p < 0.001. For abbreviations, check Fig. 3.

 
On the basis of these results, it was interesting to establish the specific behavioral and transcriptional role of the histaminergic system on 3-NP effects as well as distinguishing whether these effects were caused by intrinsic neuronal alterations. An acute dose of this neurotoxin, given after the sequential injection of selective H1,3R antagonists, provided mixed expressing pattern of both subtypes. This was particularly evident for H1R-expressing neurons as demonstrated by the sequential administration of pyrilamine and cimetidine that, although did not interfere with the 3-NP-dependent motor behaviors, did invert the effects of the neurotoxin on H1R expression levels in both rodents as displayed by a very strong increase (>80%, p < 0.001) in the hamster striatum and rat COR III (Fig. 6a), whereas a moderate (>40 < 60%, p < 0.05) up-regulation of H3R mRNA-expressing neurons was mostly found in hamster brain areas with the exception of the rat striatum (Fig. 6b). However, it was the H3R antagonist thioperamide, specific for the inhibition of hamster 3-NP-dependent motor behaviors that, aside from the striatum and COR III of both rodents, showed predominantly very strong (>150%, p < 0.001) up-regulatory effects of H1R subtype in especially the Ce and Lat sites of this hibernating rodent (Fig. 6c), whereas no significant changes were reported for H3R (Fig. 6d).



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6. Effects of histamine antagonists on H1,3R transcriptional activities in 3-NP-induced symptomatics (n = 5) that received an acute dose as described in Fig. 4. Transcription expression differences (percent mean ± S.E.M.) of the two subtypes refer to H1R (a and c) and H3R (b and d) mRNA ratios of symptomatic hamster (black square with white dots) and rat (white square with black dots) treated with H1/2R (a and b) or H3R (c and d) antagonists with respect to symptomatic without antagonists and compared with their corresponding controls (vertical and horizontal line, respectively) as described under Materials and Methods. *, p < 0.05; **, p < 0.01; ***, p < 0.001. For abbreviations, check Fig. 3.

 

    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
The differential role of the histaminergic signaling system toward 3-NP-dependent neurodegenerative disorders in the hamster with respect to the rat show, for the first time, that this hibernating rodent is a very useful model for studying neuromolecular mechanisms operating in neuropathological disorders such as AD. In the present work, such a signaling system has been shown to promote protective measures that in this and other hibernating rodents might prove to be critical, especially during particular stages of hibernation such as arousal, a physiological stage in which the hamster is exposed to particular degenerative events, namely those of the ischemic type (Stenzel-Poore et al., 2003Go).

At the structural level, the different 3-NP doses proved to be responsible for evident structural damages that were easily observed with the light microscope using amino cupric silver staining methods. This method has proven to be a helpful tool for the detection of degenerative processes in neuronal cell bodies, dendrites, and axons as well as the surveying of cell damage in primary sites of trauma (De Olmos et al., 1994Go). It was, however, at the ultrastructural level that substantial neurodegenerative processes induced by the different doses of 3-NP were shown to occur in a more selective manner. As a matter of fact, greater structural alterations consisting of an increased number of neurons that displayed an evident dark nucleus plus crenated cell membrane and phenomena of vacuolation appeared to prevalently characterize the different brain regions such as the striatum and cortex of the rat, which is in line with the very early acute damages involving membrane thickness and dilated cisternal formations in the former brain area of this same animal under the influence of the freckled milk vetch-derived neurotoxin (Seaman and Phelix, 2005Go). Conversely, a low number of unimpaired mitochondrial crests were instead reported for hamster brain areas such as the amygdala with respect to the greater number reported for the rat and other rodent brain areas for that matter (La Fontaine et al., 2000Go). The fewer structural alterations in this telencephalic region of hamster is supported by the low number of damaged dendrites detected in this same brain region of animals exposed to other degenerative-dependent events like stress (Vyas et al., 2002Go). A feature that appears to be accompanied by an abundance of neuronal elements, probably of the A-potassium current type (Graß et al., 2004Go). These elements may serve as a buffer system for the excess production of traumatic neuronal products and at the same time play a major role for the consequential synaptogenetic plasticity responses not only for ischemic insults (Arendt, 2004Go) but also against 3-NP-induced abnormal motor behaviors.

Recently, the demonstration of 3-NP effects accounting for neurotransmission dysfunctions (Saulle et al., 2004Go) tends to suggest the importance of certain neuromediating systems, such as the histaminergic fibers in the neurodegenerative processes of hibernating animals (Epperson and Martin, 2002Go). A relationship that appears to be very tightly linked to the distinct expression pattern of H1,3R subtypes in both rodents as suggested by recent results showing diminished and increased mRNA levels of the two subtypes, respectively, in cortical plus other brain regions such as the hypothalamus and hippocampus of the hibernating hamster with respect to nonhibernating and the rat for that matter (M. Madeo, T. Granata, R. M. Facciolo, A. Carelli, S. Tripepi, and M. Canonaco, unpublished data). It is noteworthy that the low expressing levels of this subtype in the major motor centers such as the striatum and cortex of the hamster treated with 3-NP seem to fit very nicely with the low levels of H1RinAD patients (Higuchi et al., 2000Go) and accelerated kindling seizures (Chen et al., 2003Go). On the other hand, high expression levels of H3R, especially in amygdalar areas as well as the cortex layers of the hamster treated with 3-NP, appear to be consistent with species-specific responses as shown by an up-regulation of this subtype in striatum of stressed rats (Ito et al., 1999Go) as compared with a down-regulation in diencephalic areas of other pathological states such as status epilepticus in the rat (Jin et al., 2005Go). Moreover, even environmental-related stressful conditions tend to play a determinant role on the transcriptional activity of this subtype as confirmed by the varying photoperiodic effects accounting for a down-regulating trend of H3R mRNA levels in the same brain region of another species, the Siberian hamster (Barrett et al., 2005Go).

Indeed, the high expressing activity of H3R neurons in the Syrian golden hamster, which is comparable with the same levels detected during the stressful moments of hibernation, i.e., blocking of the arousal phase probably through the inhibition of hippocampal activity (Sallmen et al., 2003Go), appears to be in good agreement with the motor difficulties displayed by Parkinson's disease patients displaying similar subtype levels (Anichtchik et al., 2001Go). Interestingly, the inhibition of H3R influences on 3-NP-dependent abnormal motor behaviors via its antagonist, thioperamide (M. Madeo, G. Giusi, R. Alò, T. Granata, E. Perrotta, R. M. Facciolo, A. Carelli, M. Canonaco, personal communication), plus the concomitant induction of elevated H1R mRNA-expressing neurons, tend to further emphasize the potential neuroprotective role of this latter subtype against freckled milk vetch-derived neurotoxin effects. Hence, it is not surprising that the specific H3R antagonist is capable of reducing brain lesions in interleukin-9-activation of cerebral palsy (Patkai et al., 2001Go). Conversely, H1R/H2R antagonists are more inclined to accelerate ischemic brain damages (Otsuka et al., 2003Go), a condition that appears to be tightly correlated to the low expression levels of H1R that are instead typical of cortical areas of nonmotivated motor syndromes as in the case of depressed patients (Kano et al., 2004Go).


    Conclusions
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
In this field, little is still known about the mechanism by which the histaminergic signaling system might be operating toward the protection of 3-NP-dependent neurodegenerative cellular processes and, consequently, the almost normal motor behaviors in hibernating rodents, a difference that was clearly observed by the fewer neuronal alterations in brain regions of the hamster than in the rat. Moreover, the high expression levels of H1R following the blockade of H3Rs plus the recent detection of the elevated transcription pattern of another major cellular stress factor, i.e., heat shock proteins (unpublished data) in the amygdala, supply convincing evidence that this limbic region and the increased expression of H1R, together with low H3R mRNA levels in another hibernating species (Barrett et al., 2005Go), may turn out to be key protective components for the different brain regions of patients with neurodegenerative disorders.


    Acknowledgements
 
We thank Enrico Perrotta (Electron Microscope Laboratory, Ecology Department, University of Calabria, Cosenza, Italy) for the expert technical assistance with transmission electron microscopy.


    Footnotes
 
This work was supported in part by the contract sponsor of cofinanced projects of Ministero dell'Istruzione, dell'Università e della Ricerca (Italy).

doi:10.1124/jpet.105.088153.

ABBREVIATIONS: HnR, histamine receptor subtypes; AD, Alzheimer's disease; 3-NP, 3-nitropropionic acid; PCR, polymerase chain reaction; COR, cortex; Lat, lateral amygdala nucleus; Ce, central amygdala nucleus.

Address correspondence to: Marcello Canonaco, Comparative Neuroanatomy Laboratory, Ecology Department, University of Calabria, Ponte P. Bucci, 87030 Arcavacata di Rende, Cosenza, Italy. E-mail: canonaco{at}unical.it


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 

Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, and Panula P (2001) Distribution and modulation of histamine H3 receptor in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8: 707–716.[CrossRef][Medline]

Arendt T (2004) Neurodegeneration and plasticity. Int J Dev Neurosci 22: 507–514.[Medline]

Balleine BW, Killcross AS, and Dickinson A (2003) The effect of lesions of the basolateral amygdala on instrumental conditioning. J Neurosci 23: 666–675.[Abstract/Free Full Text]

Barrett P, Ross AW, Balik A, Littlewood PA, Mercer JG, Moar KM, Sallmen T, Kaslin J, Panula P, Schuhler S, et al. (2005) Photoperiodic regulation of histamine H3 receptor and VGF messenger ribonucleic acid in the arcuate nucleus of the Siberian hamster. Endocrinology 146: 1930–1939.[Abstract/Free Full Text]

Bizat N, Hermel JM, Boyer F, Jacquard C, Creminon C, Ouary S, Escartin C, Hantraye P, Kajewski S, and Brouillet E (2003) Calpain is a major cell death in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J Neurosci 23: 5020–5030.[Abstract/Free Full Text]

Brambrink AM, Noga H, Astheimer A, Heimann A, and Kempski O (2004) Pharmacological preconditioning in global cerebral ischemia. Acta Neurochir Suppl 89: 63–66.

Chen Z, Li Z, Sakurai E, Izadi Mobarakeh J, Ohtsu H, Watanabe T, Watanabe T, Iinuma K, and Yanai K (2003) Chemical kindling induced by pentylenetetrazol in histamine H1 receptor gene knockout mice (H KO), histidine decarboxylase-deficient mice (HDC–/–) and mast cell-deficient W/WV mice. Brain Res 968: 162–166.[CrossRef][Medline]

De Olmos JS, Beltramino CA, and De Olmos De Lorenzo S (1994) Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia and physical trauma. Neurotoxicol Teratol 16: 545–561.[CrossRef][Medline]

Deshpande SB, Fukuda A, and Nishino H (1997) 3-Nitropropionic acid increases the intracellular Ca2+ in cultured astrocytes by reverse operation of Na+-Ca2+ exchanger. Exp Neurol 145: 38–45.[CrossRef][Medline]

Epperson LE and Martin SL (2002) Quantitative assessment of ground squirrel mRNA levels in multiple stages of hibernation. Physiol Genomics 10: 93–102.[Abstract/Free Full Text]

European Communities Council Directive (1986) Guide for use and care of laboratory animals. Off J Eur Commun 358: 1–29.

Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, Bioulac B, and Tison F (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57B1/6 mice: behavioural and histopathological characterisation. Neuroscience 114: 1005–1017.[Medline]

Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, et al. (2005) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl) benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313: 176–190.[Abstract/Free Full Text]

Graß D, Pawlowski PG, Hirrlinger J, Papadopulos N, Richter DW, Kirchhoff F, and Hülsmann S (2004) Diversity of functional astroglial properties in the respiratory network. J Neurosci 24: 1358–1365.[Abstract/Free Full Text]

Haas H and Panula P (2003) The role of histamine and the tuberomammillary nucleus in the nervous system. Nat Rev Neurosci 4: 121–130.[Medline]

Higuchi M, Yanai K, Okamura N, Meguro K, Arai H, Itoh M, Iwata R, Ido T, Watanabe T, and Sasaki H (2000) Histamine H1 receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 99: 721–729.[CrossRef][Medline]

Ito C, Shen H, Toyota H, Kubota Y, Sakurai E, Watanabe T, and Sato M (1999) Effects of the acute and chronic restraint stresses on the central histaminergic neuron system of Fischer rat. Neurosci Lett 262: 143–145.[Medline]

Jin CY, Lintunen M, and Panula P (2005) Histamine H1 and H3 receptors in the rat thalamus and their modulation after systemic kainic acid administration. Exp Neurol 194: 43–56.[Medline]

Kano M, Fukudo S, Tashiro A, Utsumi A, Tamura D, Itoh M, Iwata R, Tashiro M, Mochizuki H, Funaki Y, et al. (2004) Decreased histamine H1 receptor binding in the brain of depressed patients. Eur J Neurosci 20: 803–810.[Medline]

Kia HK, Yen G, Krebs CJ, and Pfaff DW (2002) Colocalization of estrogen receptor alpha and NMDA-D mRNAs in amygdaloid and hypothalamic nuclei of the mouse brain. Mol Brain Res 104: 47–54.[Medline]

Kuljis RO, Xu Y, Aguila MC, and Baltimore D (1997) Degeneration of neurons, synapses and glial activation in a murine Atm knockout model of ataxiatelangiectasia. Proc Natl Acad Sci USA 94: 12688–12693.[Abstract/Free Full Text]

La Fontaine MA, Geddes JW, Banks A, and Butterfield DA (2000) 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease. Brain Res 858: 356–362.[CrossRef][Medline]

Leurs R, Bakker RA, Timmerman H, and de Esch IJ (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4: 107–120.[CrossRef][Medline]

Morin LP and Wood RI (2001) A Stereotaxic Atlas of the Golden Hamster Brain, Elsevier, New York.

Orthen-Gambill N and Salomon M (1992) FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats. Physiol Behav 51: 891–893.[Medline]

Otsuka R, Adachi N, Hamami G, Liu K, Yorozuya T, and Arai T (2003) Blockade of central histaminergic H2 receptors facilitates catecholaminergic metabolism and aggravates ischemic brain damage in the rat telencephalon. Brain Res 974: 117–126.[CrossRef][Medline]

Pang Z and Geddes JW (1997) Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J Neurosci 17: 3064–3073.[Abstract/Free Full Text]

Panula P, Karlstedt K, Sallmen T, Peitsaro N, Kaslin J, Michelsen KA, Anichtchik O, Kukko-Lukjanov T, and Lintunen M (2000) The histaminergic system in the brain: structural characteristics and changes in hibernation. J Chem Neuroanat 18: 65–74.[Medline]

Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, and Lin JS (2002) Anatomical, physiological and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22: 7695–7711.[Abstract/Free Full Text]

Patkai J, Mesples B, Dommergues MA, Fromont G, Thornton EM, Renauld JC, Evrard P, and Gressen P (2001) Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res 50: 222–230.[Medline]

Paxinos G and Watson C (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.

Sakata T, Yoshimatsu H, and Kurokawa M (1997) Thermoregulation modulated by histamine in rats. Inflamm Res 46: 35–36.[Medline]

Sallmen T, Lozada AF, Anichtchik OV, Beckman A, and Panula P (2003) Increased brain histamine H3 receptor expression during hibernation in golden-mantled ground squirrels. BMC Neuroscience 4: 24–33.[CrossRef][Medline]

Saulle E, Gubellini P, Picconi B, Centonze D, Tropepi D, Pisani A, Morari M, Marti M, Rossi L, Papa M, et al. (2004) Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Mol Cell Neurosci 25: 9–20.[CrossRef][Medline]

Seaman RL and Phelix CF (2005) Acute effects of pulsed microwaves and 3-nitropropionic acid on neuronal ultrastructure in the rat caudate-putamen. Bioelectromagnetics 26: 82–101.[Medline]

Stenzel-Poore M, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, et al. (2003) Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362: 1028–1037.[CrossRef][Medline]

Ueda S and Ibuka N (1995) An analysis of factors that induce hibernation in Syrian hamsters. Physiol Behav 58: 653–657.[CrossRef][Medline]

Vyas A, Mitra R, Rao BSS, and Chattarji S (2002) Chronic stress induces contrasting patterns of dendritic remodelling in hippocampal and amygdaloid neurons. J Neurosci 23: 6810–6818.


This article has been cited by other articles:


Home page
J EndocrinolHome page
M. Canonaco, G. Giusi, A. Madeo, R. M. Facciolo, R. Lappano, A. Canonaco, and M. Maggiolini
A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein-coupled receptor 30 in some brain areas of the hamster
J. Endocrinol., January 1, 2008; 196(1): 131 - 138.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.088153v1
315/1/188    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canonaco, M.
Right arrow Articles by Facciolo, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canonaco, M.
Right arrow Articles by Facciolo, R. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*3-NITROPROPIONIC ACID
Medline Plus Health Information
*Degenerative Nerve Diseases


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition